EntryPoint Capital’s Anterix ATEX Stock Holding History
Bought
Maintained
Sold
Other funds holding ATEX
OCAM
HCL
VCM
QF
PM
GI
EntryPoint Capital's ATEX Position: Q1 2026 in Review
EntryPoint Capital sold out of Anterix (ATEX) in Q1 2026, closing a stake of 15,012 shares — an estimated $328K sold.
EntryPoint Capital first reported a position in ATEX in Q3 2024 and held it in 3 quarters. The position peaked at $413K in Q3 2025. 132 funds tracked by Wall St. Rank hold ATEX as of Q1 2026.
- EntryPoint Capital reported no remaining Anterix position as of Q1 2026 after selling out during the quarter.
- EntryPoint Capital sold 15,012 Anterix shares in Q1 2026, an estimated $328K.
- EntryPoint Capital first reported a position in Anterix in Q3 2024 and held it in 3 quarters.
- EntryPoint Capital's Anterix position peaked at $413K in Q3 2025.
- 132 funds tracked by Wall St. Rank held Anterix as of Q1 2026.
Based on EntryPoint Capital's 13F filing for Q1 2026, filed 14 May 2026.